Form 8-K - Current report:
SEC Accession No. 0001213900-24-089354
Filing Date
2024-10-21
Accepted
2024-10-21 17:17:29
Documents
14
Period of Report
2024-10-17
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea0217938-8k_180life.htm   iXBRL 8-K 33868
  Complete submission text file 0001213900-24-089354.txt   253757

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atnf-20241017.xsd EX-101.SCH 3763
3 XBRL DEFINITION FILE atnf-20241017_def.xml EX-101.DEF 26613
4 XBRL LABEL FILE atnf-20241017_lab.xml EX-101.LAB 36680
5 XBRL PRESENTATION FILE atnf-20241017_pre.xml EX-101.PRE 25237
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0217938-8k_180life_htm.xml XML 5816
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 241384190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)